contrave vs semaglutide vs. Ozempic: A head-to-head comparison for weight loss Contrave vs. Wegovy For Weight

Abstract Tirzepatide is the first dual long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist indicated for the treatment of type 2 diabetes in adults, for reducing excess body weight and maintaining long-term weight reduction in adults with obesity or overweight and at least one weight-related comorbid condition, and for treating obstructive sleep apnea in adults with obesity

Given the overlap between intracranial hypertension and migraine, these findings are relevant to the broader migraine question

Liraglutide (a daily injection) resulted in a more modest average weight reduction of around 45%, based on 24 trials (9937 participants), but still increased the proportion of people achieving meaningful weight loss compared with placebo

You may notice an increase in energy for daily activities and overall well-being

Use-case framing: Need broad endocrine support over months